Revance Therapeutics | 보통주 자본

Ordinary Share Capital 변화 날짜
AbbVie USD 18M 0 2023-09
ALKERMES USD 1.72M 2K 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Cara Therapeutics USD 54K 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Merck USD 1.79B 0 2023-09
Neurocrine Biosciences USD 100K 0 2023-09
P&G USD 4.01B 0 2023-12
Pacira USD 46K 0 2023-12
Revance Therapeutics USD 88K 0 2023-09
Supernus Pharmaceuticals USD 55K 0 2023-12



Revance Therapeutics 보통주 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.